Ignaz Semmelweis Theory Induced Blindness the Etiology of - - PowerPoint PPT Presentation

ignaz semmelweis theory induced blindness the etiology of
SMART_READER_LITE
LIVE PREVIEW

Ignaz Semmelweis Theory Induced Blindness the Etiology of - - PowerPoint PPT Presentation

Ignaz Semmelweis Theory Induced Blindness the Etiology of Psychiatric Disorders Steve Love, MPA, LMSW Clinical Social Worker Kalamazoo Psychiatric Hospital stevelove.net Miasma A theory of infectious disease An emanation or an


slide-1
SLIDE 1

Ignaz Semmelweis Theory Induced Blindness the Etiology of Psychiatric Disorders

Steve Love, MPA, LMSW Clinical Social Worker Kalamazoo Psychiatric Hospital stevelove.net

slide-2
SLIDE 2

Miasma

A theory of infectious disease

“An emanation or an atmosphere, whether from the earth itself or from some particular area, that hovers in the surroundings and causes sickness in those exposed to it, by the pervasiveness of its malign presence."

Nuland, 2003, p. 66

slide-3
SLIDE 3

Florence Nightingale

“The very first canon of nursing… [is] TO KEEP THE AIR HE BREATHES AS PURE AS THE EXTERNAL AIR, WITHOUT CHILLING HIM”

Nightingale 1860, p. 12

slide-4
SLIDE 4

Growing cities = growing squalor and smell

London’s Great Stink: ...The intense heat had driven our legislators from those portions of their buildings which overlook the river...

The Times, 1858

slide-5
SLIDE 5
slide-6
SLIDE 6

Vienna General Hospital 1774

slide-7
SLIDE 7

Ignaz Semmelweis

  • Born in Buda, Hungary in 1818
  • Graduated with a degree in medicine

from the University of Vienna in 1844

  • Began an assistant professorship at

the Vienna General Hospital in July

  • f 1846
slide-8
SLIDE 8

Childbed Fever (puerperal fever)

  • Infectious disease following childbirth or miscarriage
  • Often fatal if untreated
  • Symptoms: fever, vaginal discharge, abdominal pain and

swelling of connective tissue and abdomen

slide-9
SLIDE 9

Only Midwives working in Division 2

slide-10
SLIDE 10

His observations

1. Division 1 was staffed by doctors - Division 2 was staffed by midwives 2. Women were less likely to die of childbed fever in the streets 3. Death rates were not linked to weather 4. Greater physical trauma resulted in greater chance of contracting childbed fever 5. Closing the ward and moving the patients would cease the deaths 6. Infants of mothers who died often died of similar symptoms

Nuland, 2003

slide-11
SLIDE 11

Discovering causality

In 1847, when Jakob Kolletschka died after his finger was pricked during an autopsy. Semmelweis realized the following

  • Kolletschka’s symptoms matched childbed fever symptoms
  • Cadaver particles were the cause of the infection
  • Women were being infected by doctors conducting autopsies

Nuland, 2003

slide-12
SLIDE 12

Cause = Intervention

After making his discoveries, Semmelweis “insisted that every entering medical attendant wash in [a bowl of chloride solution] before touching a woman in labor”1

Nuland, 2003, p. 101

slide-13
SLIDE 13

Implementation of handwashing

slide-14
SLIDE 14

Miasma Wins Out1

  • Hospital director reinterpreted the

data based on miasma - ascribed to the new ventilation system

  • 1849: Semmelweis was ousted by

the older physicians

  • 1865: Semmelweis, age 47, was

admitted to a psychiatric hospital and died two weeks later from wounds likely sustained from a fight with the guards

Nuland, 2003

slide-15
SLIDE 15

Why Semmelweis Failed: Theory Induced Blindness

“Once you have accepted a theory and used it as a tool in your thinking, it is extraordinarily difficult to notice its flaws. If you come upon an

  • bservation that does not seem to fit the model, you assume that there

must be a perfectly good explanation that you are somehow missing. You give the theory the benefit of the doubt, trusting the community of experts who have accepted it.”

Kahneman, 2011, p. 277

slide-16
SLIDE 16
  • Dominant explanatory theory
  • Data that contradicts the dominant theory
  • Failure to integrate contradictory data
  • Hostility towards those who challenge the theory

Characteristics of Theory Induced Blindness

slide-17
SLIDE 17

What about mental health?

Biological pathology = Modern miasma

slide-18
SLIDE 18

Modern miasma

Emil Kraepelin (19th century) “An understanding of the symptomatology of an illness will, we hope, result above all from GENETIC research."

Kraepelin, 1992, p. 516

slide-19
SLIDE 19

Modern miasma

  • Psychoanalysts dominated without causality
  • 1952: with the advent of Chlorpromazine, the

search for the biological cause was renewed

  • Chemical Imbalance

○ “always a kind of urban legend, never a theory seriously propounded by well- informed psychiatrists”1

  • Genetic search

○ “this promise, which we have anticipated since the 1970s, remains disappointingly distant.”2

1: Pies, 2011, para. 1 2: Kupfer, 2013, para. 1

slide-20
SLIDE 20

Modern miasma

  • Brain pathology

○ “Nevertheless, the spirit of a revolution— the sense that we are going to change things dramatically, even if the process requires a number of years— is very much present”1 ○ We hope to "at long last, reaching an inflection point at which insights gained from genetics and neuroscience would transform the understanding of psychiatric illnesses"2

1: Andreasen, 1984, p. 138 2: Insel, 2010, p. 1970

slide-21
SLIDE 21

Modern Miasma

  • A turn toward epigenetics

○ This theory would be able to “detect molecular effects of experience... [that] point to diverse molecular pathways that confer risk of mental illness"1

  • Current estimation

○ It is so complex that it requires “genetics, gene expression/epigenetics, changes in neuronal activity, and differences in dynamics at the micro and macro levels, depending

  • n the mood state”2

1: Insel, 2010, p. 1970 2: Akil, 2011, p. 711

slide-22
SLIDE 22

The fact remains

  • Schizophrenia is “a disease whose mechanisms are totally unknown”1
  • More broadly, psychiatric disorders have "no validated biomarkers"2

1: Holden, 2003, p. 333 2: Insel, 2010, p. 1971

slide-23
SLIDE 23

Unmedicated vs Medicated

Division 1: Doctors Medicated ? Division 2: Midwives Unmedicated

slide-24
SLIDE 24

Unmedicated outcomes

slide-25
SLIDE 25

Unmedicated Bipolar and Depression

  • 1955: 1 in 4,345 Americans hospitalized for depression1
  • 1875-1924: 1 in 100,000 Bipolar Disorder in Wales2

1: Silverman, 1968 2: Healy, 2011

slide-26
SLIDE 26

“Depression is, on the whole, one of the psychiatric conditions with the best prognosis for eventual recovery, with or without treatment. Most depressions are self-limited.”

Unmedicated Bipolar and Depression

Cole, 1964, p. 448

slide-27
SLIDE 27

“assurance can be given to a patient and to his family that subsequent episodes

  • f illness after a first mania or even a first depression will not tend toward a

more chronic course…”1 there was “no basis to consider that manic depressive psychosis permanently affected those who suffered from it… [since] in a significant number of patients,

  • nly one episode of illness occurs."2

Unmedicated Bipolar and Depression

Winokur, 1969, p. 19 Winokur, 1969, p. 21

slide-28
SLIDE 28
  • Warren State Hospital 1946-19501

○ 1 year out: 62% discharged ○ 3 years out: 73% discharged

  • Delaware State Hospital 1948-19501

○ 6 years out: 70% discharged

  • Harrow’s NIMH Study (2007), 15 years out2

○ 40% recovery rate in those who discontinued medication post hospitalization.

Unmedicated Schizophrenia

1: Cole, 1959 2: Harrow, 2007

slide-29
SLIDE 29

Medicated Schizophrenia

slide-30
SLIDE 30
  • NIMH’s first long term study (1967)

○ 4 groups: Thioridazine/Mellaril, Fluphenazine/Prolixin, Chlorpromazine/Thorazine, Placebo ○ 1 year out, placebo group was “less likely to be rehospitalized than those who received any of the three active phenothiazines.”

Medicated Schizophrenia

Schooler, 1967, p. 991

slide-31
SLIDE 31
  • Comparing 5 year outcomes of 1947 to 1967

○ 1967 group ■ A “larger proportion of patients tend to relapse” ■ They are more “socially dependent” ■ “rather unexpectedly, these data suggest that psychotropic drugs may not be indispensable. Their extended use in aftercare may prolong the social dependency of many discharged patients.”

Medicated Schizophrenia

Bockoven, 1975, p. 801

slide-32
SLIDE 32

Medication use (in hospital/after discharge) Number of Patients Severity of Illness (1=best outcome 7=worst outcome) Rehospitalization No meds/off 24 1.7 8% Antipsychotics/off 17 2.79 47% No meds/on 17 3.54 53% Antipsychotics/on 22 3.51 73%

Medicated Schizophrenia

Rappaport, 1978

slide-33
SLIDE 33
  • Comparing relapse on and off antipsychotics

○ “Drug failures appeared to have a considerably higher hospitalization rate than placebo relapsers” ○ “Patients who relapse on medications are sicker than placebo relapsers”

Medicated Schizophrenia

Gardos, 1976, p. 34

slide-34
SLIDE 34

Medicated outcomes cont.

  • 50 year review of antipsychotics

○ “It cannot be denied that there is currently no compelling evidence

  • n the matter, where ‘long-term’ is concerned”1
  • Harrow’s NIMH Study: 20 years out (Harrow)

○ Continuously medicated: 17% ever entered into a period of recovery ○ Went off medication at 2 years: 87% experienced two or more periods of recovery2

1: Stip, 2002, p. 117 2: Harrow, 2012

slide-35
SLIDE 35

Psychiatric Disability Rates

  • Adult disability rates in the United States:

○ 1955: 1 in every 4681 ○ 1987: 1 in every 1841 ○ 2003: 1 in every 732 ○ 2013: 1 in every 592

  • Child disability rates in the United States:

○ 1987: 16,2001 ○ 2007: 561,5691

  • The average cost of a 20 year old disabled: $1 million/per person1
  • Similar increases have been established in Australia3 and Iceland4

1: Whitaker, 2010 2: Social Security Administration 2004/2014 3: Department of Social Services 2001/2013 4: Thorlacious, 2010

slide-36
SLIDE 36

Modern handwashing Alternatives in care

slide-37
SLIDE 37
  • Cognitive behavioral therapy:

○ Meta Analysis: depression, generalized anxiety disorder, panic disorder, social phobia, posttraumatic stress disorder, and other disorders1 ○ Initial onset2 and relapse prevention bipolar disorder3 ○ Schizophrenia4

Talk therapy

1: Butler, 2006 2: Scott, 2006 3: Lam, 2003 4: Wykes, 2007

slide-38
SLIDE 38
  • Psychodynamic therapy demonstrated to have a measurable impact
  • n prefrontal-limbic functioning1
  • Cognitive enhancement therapy provides a protective factor against

gray matter loss in schizophrenia2

Talk therapy

1: Buchheim, 2012 2: Eack, 2010

slide-39
SLIDE 39

Music Therapy and Schizophrenia

“Music therapy as an addition to standard care helps people with schizophrenia to improve their global state, mental state (including negative symptoms) and social functioning if a sufficient number of music therapy sessions are provided by qualified music therapists.”

Mossler, 2011, p. 2

slide-40
SLIDE 40
  • ADHD

○ Exercise for ADHD “has been shown to be effective in controlling ADHD symptoms, has essentially no side effects… [and] produces physical, mental, and emotional advantages that are far reaching and more complex” in comparison to medications1

  • Depression

○ Meta-analysis: 11 studies showed “a very large combined effect size for the advantage of exercise”2

  • Anxiety

○ Meta analysis: There is strong “evidence for the use of exercise as a treatment for anxiety disorders.”3

Exercise and Anxiety

1: Lenz, 2012, p. 308 2: Stathopoulou, 2006, p. 188 3: Wipfli, 2008, p. 404

slide-41
SLIDE 41
  • Specialist First Episode Psychosis adjunctive programs statistically

beneficial for individuals in comparison to treatment-as-usual1

  • Open Dialogue, 5 year follow-up:2

○ 73% working or studying in a formal setting ○ 29% exposed to antipsychotics

  • Group based psychosocial adjunctive intervention was superior to

treatment-as-usual3

Bipolar and Schizophrenia

1: Alvarez-Jimenez, 2009 2: Seikkula, 2006 3: Castle, 2010

slide-42
SLIDE 42
  • PERMA: Positive emotions, Engagement, positive Relationships,

Meaning, Achievement1

  • Logging blessings on a daily basis2
  • Story editing3

Positive Psychology

1: Seligman, 2011 2: Emmons, 2003 3: Wilson, 2011

slide-43
SLIDE 43

Scientific Method

“Principles and procedures for the systematic pursuit of knowledge involving the recognition and formulation of a problem, the collection of data through observation and experiment, and the formulation and testing

  • f hypotheses”

Merriam-Webster, 2015

slide-44
SLIDE 44

First, do no harm

“the traditional Hippocratic moral obligation of medicine is to provide net medical benefit to patients with minimal harm that is, beneficence with non- maleficense.” “The obligation to provide net benefit to patients also requires us to be clear about risk and probability when we make our assessments of harm and benefit.”

Gillon, 1994, p. 185

slide-45
SLIDE 45

Are we suffering from Theory Induced Blindness?

slide-46
SLIDE 46

References

Thinker image: https://www.flickr.com/photos/sidereal/349496270 Nuland S. The doctors' plague. New York: W.W. Norton; 2003. p. 66 Nightingale F. Notes on nursing: What it is, and what it is not. New York: D. Appleton and Company; 1860 Great Stink Quote: The Times on June 18th, 1858 Kahneman D. Thinking, fast and slow. New York: Farrar, Straus and Giroux; 2011. Kraepelin E. Die Erscheinungsformen des Irreseins: (The manifestations of insanity). History of Psychiatry. 1992;3(12):509-529. Pies R. Psychiatry’s New Brain-Mind and the Legend of the “Chemical Imbalance” [Internet]. Psychiatric Times. 2011 [cited 1 March 2015]. Available from: http://www.psychiatrictimes.com/blogs/couch-crisis/psychiatry-new-brain-mind-and- legend-chemical-imbalance Kupfer D. Statement from DSM Chair David Kupfer, MD [Internet]. Psychiatry.org. 2013 [cited 1 March 2015]. Available from: http://www.psychiatry.org/advocacy--newsroom/newsroom/statement-from-dsm-chair-david-kupfer-md Andreasen N. The broken brain. New York: Harper & Row; 1984. Insel T, Wang P. Rethinking Mental Illness. JAMA. 2010;303(19):1970. Akil H, Martone M, Van Essen D. Challenges and Opportunities in Mining Neuroscience Data. Science. 2011;331(6018):708-712. Holden C. NEUROSCIENCE: Deconstructing Schizophrenia. Science. 2003;299(5605):333-335. Silverman C. The Epidemiology of Depression. Baltimore: Johns Hopkins Press; 1968. Healy D. Mania. Baltimore: Johns Hopkins University Press; 2011. Cole J. Therapeutic Efficacy of Antidepressant Drugs. JAMA. 1964;190(5). Winokur G, Clayton P, Reich T. Manic depressive illness. St. Louis: C.V. Mosby; 1969. Cole J, Gerard R. Psychopharmacology problems in evaluation. Washington: National Academy of Sciences, National Research Council; 1959.

slide-47
SLIDE 47

References

Harrow M, Jobe T. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15- year multifollow-up study. The Journal of Nervous and Mental Disease. 2007;195(5). SCHOOLER N, GOLDBERG S, BOOTHE H, COLE J. One Year After Discharge: Community Adjustment of Schizophrenic Patients. AJP. 1967;123(8):986-995. Bockoven J, Solomon H. Comparison of two five-year follow-up studies: 1948 to 1952 and 1967 to 1972. American Journal of

  • Psychiatry. 1975;132(8):796-801.

Rappaport M, Hopkins H, Hall K, Belleza T, Silverman J. Are there schizophrenics for whom drugs may be unnecessary or

  • contraindicated. International pharmacopsychiatry. 1978;13(2):100-11.

Gardos G, Cole J. Maintenance antipsychotic therapy: is the cure worse than the disease?. American Journal of Psychiatry. 1976; 133(1):32-36. Stip E. Happy birthday neuroleptics! 50 years later: la folie du doute. European Psychiatry. 2002;17(3):115-119. Harrow M, Jobe T, Faull R. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychological Medicine. 2012;42(10):2145-2155. Whitaker R. Anatomy of an Epidemic. New York: Crown Publishers; 2010. Social Security Administration, Office of Policy, Office of Research, Evaluation, and Statistics. Annual statistical report on the Social Security Disability Insurance Program, 2003. Baltimore: United States; 2004. Social Security Administration, Office of Policy, Office of Research, Evaluation, and Statistics. Annual statistical report on the Social Security Disability Insurance Program, 2013. Baltimore: United States; 2014. Department of Social Services. Characteristics of Disability Support Pension Recipients. Canberra: Business Data and Analytics Branch; 2001. Department of Social Services. Characteristics of Disability Support Pension Recipients. Canberra: Business Data and Analytics Branch; 2013.

slide-48
SLIDE 48

References

Thorlacius S, Stefánsson S, Ólafsson S, Tómasson K. Increased incidence of disability due to mental and behavioural disorders in Iceland 1990–2007. J Ment Health. 2010;19(2):176-183. Fork in the Road picture: http://www.ronniefloyd.com/blog/wp-content/uploads/Choices-fork-in-the-road3.jpg BUTLER A, CHAPMAN J, FORMAN E, BECK A. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clinical Psychology Review. 2006;26(1):17-31. SCOTT J. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: Randomised controlled trial. The British Journal of Psychiatry. 2006;188(4):313-320. Lam D, Watkins E, Hayward P, Bright J, Wright K, Kerr N et al. A Randomized Controlled Study of Cognitive Therapy for Relapse Prevention for Bipolar Affective Disorder. Arch Gen Psychiatry. 2003;60(2):145. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor. Schizophrenia Bulletin. 2007;34(3):523-537. Buchheim A, Viviani R, Kessler H, Kächele H, Cierpka M, Roth G et al. Changes in Prefrontal-Limbic Function in Major Depression after 15 Months of Long-Term Psychotherapy. PLoS ONE. 2012;7(3):e33745. Eack S, Hogarty G, Cho R, Prasad K, Greenwald D, Hogarty S et al. Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early Schizophrenia. Arch Gen Psychiatry. 2010;67(7):674. Music Therapy for People with Schizophrenia and Schizophrenia-Like Disorders. The Cochrane database of systematic reviews. 2011;(12). Lenz T. A Pharmacological/Physiological Comparison between ADHD Medications and Exercise. American Journal of Lifestyle

  • Medicine. 2012;6(4):306-308.

Stathopoulou G, Powers M, Berry A, Smits J, Otto M. Exercise Interventions for Mental Health: A Quantitative and Qualitative

  • Review. Clin Psychol Sci & Pract. 2006;13(2):179-193.
slide-49
SLIDE 49

References

Wipfli B, Rethorst C, Landers D. The anxiolytic effects of exercise: a meta-analysis of randomized trials and dose-response

  • analysis. Journal of Sport & Exercise Psychology. 2008;30(4):392-410.

Alvarez-Jimenez M, Parker A, Hetrick S, McGorry P, Gleeson J. Preventing the Second Episode: A Systematic Review and Meta- analysis of Psychosocial and Pharmacological Trials in First-Episode psychosis. Schizophrenia Bulletin. 2009;37(3):619-630. Seikkula J, Aaltonen J, Alakare B, Haarakangas K, Keränen J, Lehtinen K. Five-year experience of first-episode nonaffective psychosis in open-dialogue approach: Treatment principles, follow-up outcomes, and two case studies. Psychotherapy

  • Research. 2006;16(2):214-228.

Castle D, White C, Chamberlain J, Berk M, Berk L, Lauder S et al. Group-based psychosocial intervention for bipolar disorder: randomised controlled trial. The British Journal of Psychiatry. 2010;196(5):383-388. Seligman M. Flourish. New York: Free Press; 2011. Emmons R, McCullough M. Counting blessings versus burdens: An experimental investigation of gratitude and subjective well- being in daily life. Journal of Personality & Social Psychology. 2003;84(2):377-389. Wilson T. Redirect. New York, NY: Little, Brown and Company; 2011. Merriam-webster.com. Definition of Scientific Method [Internet]. 2015 [cited 17 March 2015]. Available from: http://www. merriam-webster.com/dictionary/scientific%20method Gillon R. Medical ethics: four principles plus attention to scope. BMJ. 1994;309(6948):184-184. Star Wars picture: https://www.flickr.com/photos/jdhancock/3618602355